Commercial Trust Limited

Date authorised
31 January 2014
Companies House
08633445
Last scraped
2 weeks ago
Watch for changes

Addresses

The contact details this firm has registered with the FCA.

  • Principal Place of Business

    Commercial Trust Ltd
    Norfolk Tower
    48-52 Surrey Street
    Norwich
    Norfolk
    NR1 3PA
    UNITED KINGDOM
    Phone
    +4401603896751
    Web
    https://www.commercialtrust.co.uk

  • Complaints Contact

    Commercial Trust Ltd
    Norfolk Tower
    48-52 Surrey Street
    Norwich
    Norfolk
    NR1 3PA
    UNITED KINGDOM
    Phone
    +4401603896586

What this firm is allowed to do

The regulated activities the FCA has granted this firm permission to carry out.

  • Buy-to-Let Mortgage Advice

  • Buy-to-Let Mortgage Arranging

  • Investment Advice (no pensions)

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Mortgage Advice

    For Customer, Regulated mortgage contract

  • Authorised to Operate

    Show 1 limitation
    • · The firm can only agree to carry on the regulated activities specified in this Notice.

  • Arranges Investments

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Mortgage Arranging

    For Customer, Regulated mortgage contract

  • Buy-to-Let Start Date

  • Buy-to-Let Status

  • Credit Brokering

  • Debt Advice

    Show 2 limitations
    • · This permission is limited to debt counselling with no debt management activity
    • · This permission is limited to debt counselling which is provided in connection with buy to let mortgages

  • Mortgage Setup

    For Customer, Regulated mortgage contract

  • Investment Setup

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

Approved individuals

Senior staff personally approved by the FCA to hold their roles here.

  • Andrew Clive Turner

    IRN ACT01054

    • SMF9 Chair of the Governing Body (since 6 Apr 2020)
    • SMF1 Chief Executive (9 Dec 2019 to 22 Nov 2022)
    • SMF3 Executive Director (9 Dec 2019 to 22 Nov 2022)
    • Responsible for Insurance Distribution (1 Oct 2018 to 22 Nov 2022)
    • Responsibility for MCD Intermediation (15 Aug 2017 to 22 Nov 2022)
    • Responsible for Insurance Mediation (17 Nov 2016 to 14 Aug 2017)
    • CF1 Director (27 Oct 2015 to 8 Dec 2019)
    • CF3 Chief Executive (27 Oct 2015 to 8 Dec 2019)
    • CF2 Non Executive Director (20 Nov 2014 to 27 Oct 2015)
  • Emma Jane Harrod

    IRN EXH01319

    • CF10 Compliance Oversight (31 Jan 2014 to 13 Jun 2014)
    • CF11 Money Laundering Reporting (31 Jan 2014 to 20 Aug 2014)
  • Graham Charles Eke

    IRN GCE01014

    • CF2 Non Executive Director (13 Feb 2015 to 13 Jan 2017)
    • CF1 Director (31 Jan 2014 to 13 Feb 2015)
  • Jane Elizabeth McMahon

    IRN JEM00003

    • CF2 Non Executive Director (1 Oct 2016 to 28 Feb 2018)
  • Jonathan David Painter

    IRN JDP01106

    • CF2 Non Executive Director (6 Feb 2015 to 19 Sep 2016)
    • CF1 Director (31 Jan 2014 to 6 Feb 2015)
  • Jorden Michael Abbs

    IRN JMA01228

    • SMF1 Chief Executive (since 2 Nov 2022)
    • SMF3 Executive Director (since 9 Dec 2019)
    • Responsible for Insurance Distribution (since 1 Oct 2018)
    • Responsibility for MCD Intermediation (since 28 Mar 2018)
    • Responsible for Insurance Mediation (28 Mar 2018 to 30 Sep 2018)
    • CF1 Director (1 Feb 2018 to 8 Dec 2019)
  • Neil Laughton

    IRN NXL01150

    • CF29 Significant management (18 Aug 2014 to 12 Nov 2014)
  • Nicola Elizabeth Claire Eaton

    IRN NXE00113

    • SMF3 Executive Director (since 2 Oct 2024)
  • Paul Hollander

    IRN PXH02115

    • Director of firm who is not a certification employee or a SMF manager (since 9 Dec 2019)
    • CF2 Non Executive Director (13 Jan 2017 to 8 Dec 2019)
  • Stuart James Cunningham

    IRN SJC01464

    • CF1 Director (5 Dec 2014 to 28 Aug 2015)
    • CF3 Chief Executive (31 Jan 2014 to 28 Aug 2015)

Recent activity

Updates to this firm's record on the FCA register.

No changes recorded yet.